Trademark Overview
On Thursday, February 12, 2026, a trademark application was filed for LENJOVIQ with the United States Patent and Trademark Office. The USPTO has given the LENJOVIQ trademark a serial number of 99650055. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, February 12, 2026. This trademark is owned by Gilead Sciences Ireland UC. The LENJOVIQ trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of viral infection, fungal infection, HIV infection, fibrosis, liver diseases and disorders, hepatitis, hematological diseases and disorders, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, respiratory and pulmonary diseases and disorders, kidney and nephrotic diseases and disorders, arthritis, obesity, metabolic diseases and disorders and gastrointestinal diseases and disorders